Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers. 2021-05-8
Novartis signs an agreement with Pfizer and BioNTech to help produce their vaccine. 2021-01-29
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country. 2020-12-24
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
Kuwait's Ministry of Health approves an Emergency Use Authorization of the Pfizer-BioNtech vaccine. 2020-12-13
Officials from The Pentagon say that they will receive 44,000 doses of the Pfizer-BioNTech's Tozinameran vaccine. However, it will not be mandatory for soldiers to receive the vaccine. 2020-12-9
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
American company Pfizer and German company BioNTech announce that their vaccine could be ready for approval mid-October or early November. 2020-09-8